FIELD: organic chemistry, heterocyclic compounds, pharmacy. SUBSTANCE: invention describes the novel derivatives of O6-guanine of the general formula (I) where Y means hydrogen atom, ribosyl or deoxypibosyl that can be substituted with hydroxy- or C1-C4-aklkoxy-groups; R1 means hydrogen atom, C1-20-alkyl or hydroxy-C1-20-alkyl; R means: (i) cyclic group containing five-membered ring with at least one heteroatom taken among O, N or S and optionally condensed with benzene, pyridine or naphthalene ring or six-membered heterocyclic ring containing at least one N-atom, optionally with S-atom, optionally condensed with one or two benzene rings where indicated cyclic group can be optionally substituted in heterocyclic ring(s) and/or carbocyclic ring(s) with groups taken among C1-C5-alkyl, halogen atom, cyano-, nitro-, azido-group, C1-C5-alkoxy-group, aryl, SOnR″″ where R″″ means C1-C5-alkyl and n = 0, 1, 2, COOR5 where R5 means H or C1-C5-alkyl or N-oxides. Indicated compounds show ability to decrease activity of O6-alkylguanine DNA-alkyltransferase in tumor cells. Their activity is 8-fold above that of the known analogs. Invention describes also the composition based on compounds of the formula (I). EFFECT: new compounds indicated above, valuable biochemical and antitumor properties. 14 cl, 14 dwg, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION SHOWING ANTITUMOR ACTIVITY AND METHOD OF ITS PREPARING | 1994 |
|
RU2148401C1 |
METHOD OF CELL SELECTION IN VIVO BY USING LYSOMUSTINE | 2010 |
|
RU2425149C1 |
DERIVATIVES OF NITROGENOUS YPERITE BOUND WITH AMINO ACIDS THAT ARE PRODRUG SUBSTRATES FOR CARBOXYPEPTIDASE ENZYME, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND BIOCOMPONENT SYSTEM FOR CYTOTOXIC DRUG DELIVERY | 1993 |
|
RU2129542C1 |
1,1'-(HEXANE-1,6-DIYL)BIS(3-(((1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTAREN-1-YL)METHYL)UREA, WHICH EXHIBITS INHIBITING ACTION ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME AND INCREASES TEMOZOLOMIDE ACTIVITY ON GLIOBLASTOMA CELLS | 2019 |
|
RU2724882C1 |
HYDRATED CRYSTALLINE CAMPTOTHECIN ESTERS FOR TREATING CANCER | 2008 |
|
RU2483071C2 |
1-ADAMANTYL-3-(((1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHREN-1-YL)METHYL)UREA, WHICH EXHIBITS INHIBITING ACTION ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME AND INCREASES ACTIVITY OF TEMOZOLOMIDE AGAINST GLIOBLASTOMA CELLS | 2019 |
|
RU2697409C1 |
ONCOLOGIC SENSIBILISER WHICH CONTAINS GLUCOSAMINE, GLUCOSAMINE DERIVATIVES OR THEIR SALTS | 2006 |
|
RU2424810C2 |
COMBINED CHEMOTHERAPY AND IMMUNOTHERAPY | 2006 |
|
RU2473560C2 |
TRICYCLIC PARP INHIBITORS | 2004 |
|
RU2404183C2 |
ONCOGENE NRF2 AND ITS USE | 2009 |
|
RU2486253C2 |
Authors
Dates
2000-08-20—Published
1994-06-08—Filed